Patrik Ringblom

Director/Board Member at SPECTRACURE AB

62 year

Health Technology

Electronic Technology

Consumer Services

Profile

Patrik Ringblom is currently an Independent Director at SpectraCure AB since 2025 and Head-Strategy & US Lead at Lakefront Biotherapeutics since 2023.
Formerly, Mr. Ringblom was VP-Rare Disease Novel Therapeutics & Alliance at Johnson & Johnson from 2022 to 2023.
Mr. Ringblom completed an MBA at Handelshögskolan i Göteborg.

Patrik Ringblom active positions

Companies	Position	Start
LAKEFRONT BIOTHERAPEUTICS NV	Corporate Officer/Principal	01/10/2023
SPECTRACURE AB	Director/Board Member	01/01/2025

All active positions of Patrik Ringblom

Former positions of Patrik Ringblom

Companies	Position	End
JOHNSON & JOHNSON	Corporate Officer/Principal	01/10/2023

See the detail of Patrik Ringblom's experience

Training of Patrik Ringblom

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Patrik Ringblom's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Johnson & Johnson Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products	Health Technology
Galapagos NV Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology	Health Technology
SpectraCure AB SpectraCure AB Electronic Equipment/InstrumentsElectronic Technology Develops and provides equipment for cancer treatment	Electronic Technology
Handelshögskolan i Göteborg Handelshögskolan i Göteborg Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services